Learn the importance of using serum free light chain (sFLC) tests to enhance detection sensitivity in multiple myeloma tests to diagnose early and save lives.
Explore how serum free light chain (sFLC) tests improve sensitivity in multiple myeloma detection, helping healthcare providers diagnose early and save lives.
This website contains information which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible in your country. By selecting a different language, you are choosing to view another site. Product availability and indications may vary from what is approved in your region.
Binding Site's Immunodiagnostic Assays and Instrumentation
Optimizing Multiple Myeloma, immune system disorders, and special protein diagnostics through 35 years of scientific leadership
Latest news
Thermo Fisher Scientific Announces Extended 510k Clearance of Freelite Assays for Evaluation of MGUS, a Precursor to Multiple Myeloma
Discover the signs and symptoms of Multiple Myeloma and explore which Binding Site assays are used for detecting and monitoring purposes
Webinar
Clinical Applications
Immune System Disorders
Learn how to assess immune function and detect immunodeficiencies with Binding Site's advanced assays for immune system disorders
Committed to improving patient lives worldwide for over 30 years
Our mission, vision and values sit at the heart of everything we do. They provide a clear focus and direction for our business, defining who we are and how we work.